Although there is currently no link established between susceptibility to infections and immune dysregulation in these patients, the laboratory results were not available for most of the patients
Sotyktu is the only tyrosine kinase 2 (TYK2) inhibitor to be approved for PsA To view or add a comment, sign in FDA has approved deucravacitinib (Sotyktu) the Treatment of Adults with Active Psoriatic Arthritis based on the results of the pivotal Phase 3 POETYK PsA-1 and POETYK PsA-2 clinical trials
Those with kidney concerns may need closer monitoring, especially if side effects like nausea, vomiting, or diarrhea lead to dehydration
Retinal pigment epithelial cells have been reported to express functional GLP-1 receptors, and preclinical literature has explored retinal neuroprotection and anti-inflammatory effects
Its about addressing digestive health, stress, sleep, nutritionall the environment your body needs to do its thing